These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 6666608)

  • 1. The effect of polymorphonuclear leucocyte (PMNL) factor on human natural killer (NK) cell activity in vitro.
    Pacześniak J; Tchórzewski H
    Acta Physiol Pol; 1983; 34(2):213-26. PubMed ID: 6666608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect granulocytic factors on in vitro and in vivo activity of cytotoxic cells of guinea pigs.
    Pacześniak J
    Acta Physiol Pol; 1982; 33(4):403-13. PubMed ID: 6985186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The autocrine-paracrine modulation of natural killer activity in man by peptides of the corticostatin-defensin family].
    Masera RG; Gatti G; Bateman A; Solomon S; Sartori ML; Staurenghi A; Lazzero A; Griot G; Angeli A
    Ann Ital Med Int; 1993; 8(2):80-5. PubMed ID: 8353023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the mechanism of natural killer cytotoxicity. II. coculture of human PBL with NK-sensitive or resistant cell lines stimulates release of natural killer cytotoxic factors (NKCF) selectively cytotoxic to NK-sensitive target cells.
    Wright SC; Weitzen ML; Kahle R; Granger GA; Bonavida B
    J Immunol; 1983 May; 130(5):2479-83. PubMed ID: 6833762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of sera of breast cancer patients on NK cell activity].
    Konjević G; Spuzić I
    Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antileukemia activity of a natural killer cell line against human leukemias.
    Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
    Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of natural killer function by nonlymphoid cells.
    Shau H; Roth MD; Golub SH
    Nat Immun; 1993; 12(4-5):235-49. PubMed ID: 8257829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cytotoxic action of polymorphonuclear leukocytes on tumor and normal cells during ascite tumor development in vitro and in vivo].
    Potselueva MM; Pustovidko AV; Kovaleva EV; Shatalin IuV; Evdotienko IuV
    Tsitologiia; 2005; 47(1):57-63. PubMed ID: 16602244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
    Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts.
    Baba M; Hasegawa H; Nakayabu M; Fukai K; Suzuki S
    J Clin Lab Immunol; 1993; 40(2):47-60. PubMed ID: 7932628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mitogenic and enzymatic activities of polymorphonuclear leukocyte (PMNL) lysosomal proteins examined in vitro.
    Tchórzewski H; Sułowska Z
    Arch Immunol Ther Exp (Warsz); 1980; 28(1):1-8. PubMed ID: 6998407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of the killing mechanism of human natural killer cells against hepatocellular carcinoma cell lines HepG2 and Hep3B.
    Kim HR; Park HJ; Park JH; Kim SJ; Kim K; Kim J
    Cancer Immunol Immunother; 2004 May; 53(5):461-70. PubMed ID: 14648068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of interleukin-12 on antitumor activity of human umbilical cord blood and bone marrow cytotoxic cells.
    Condiotti R; Nagler A
    Exp Hematol; 1998 Jul; 26(7):571-9. PubMed ID: 9657131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance against natural killer cell cytotoxicity: analysis of mechanisms.
    Hasenkamp J; Borgerding A; Wulf G; Uhrberg M; Jung W; Dingeldein S; Truemper L; Glass B
    Scand J Immunol; 2006 Oct; 64(4):444-9. PubMed ID: 16970688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-D DIGE analyses of enriched secretory lysosomes reveal heterogeneous profiles of functionally relevant proteins in leukemic and activated human NK cells.
    Schmidt H; Gelhaus C; Nebendahl M; Lettau M; Watzl C; Kabelitz D; Leippe M; Janssen O
    Proteomics; 2008 Jul; 8(14):2911-25. PubMed ID: 18655029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementation of the EGFP-K562 flow cytometric NK test: determination of NK cytotoxic activity in healthy elderly volunteers before and after feeding.
    Allegra S; Deleine C; Michael-Jubely R; Gryson C; Boirie Y; Kantakamalakul W; Vasson MP
    Cytometry A; 2006 Sep; 69(9):992-8. PubMed ID: 16969797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer-cell activity after human renal transplantation in relation to killer immunoglobulin-like receptors and human leukocyte antigen mismatch.
    Vampa ML; Norman PJ; Burnapp L; Vaughan RW; Sacks SH; Wong W
    Transplantation; 2003 Oct; 76(8):1220-8. PubMed ID: 14578757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paclitaxel probably enhances cytotoxicity of natural killer cells against breast carcinoma cells by increasing perforin production.
    Kubo M; Morisaki T; Matsumoto K; Tasaki A; Yamanaka N; Nakashima H; Kuroki H; Nakamura K; Nakamura M; Katano M
    Cancer Immunol Immunother; 2005 May; 54(5):468-76. PubMed ID: 15592829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigen-specific cytolysis by neutrophils and NK cells expressing chimeric immune receptors bearing zeta or gamma signaling domains.
    Roberts MR; Cooke KS; Tran AC; Smith KA; Lin WY; Wang M; Dull TJ; Farson D; Zsebo KM; Finer MH
    J Immunol; 1998 Jul; 161(1):375-84. PubMed ID: 9647246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of human natural killer cell reactivity by exogenous adenosine 5'-triphosphate.
    Schmidt A; Ortaldo JR; Herberman RB
    J Immunol; 1984 Jan; 132(1):146-50. PubMed ID: 6690602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.